“His inspiring presence will motivate us to scale greater heights in our quest to bridge unmet healthcare needs,” Zydus Cadila said in a regulatory filing. The Zydus family comprising 25,000 Zydans stands committed to the ‘Aatmanirbhar Bharat’ mission and offering the nation safe and efficacious vaccines, therapeutics and diagnostics to fight COVID-19, it added.
Zydus Cadila had earlier announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it commenced phase-II clinical trials from August.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.